|
1
|
Liu M, Wu H, Liu T, Li Y, Wang F, Wan H,
Li X and Tang H: Regulation of the cell cycle gene, BTG2, by miR-21
in human laryngeal carcinoma. Cell Res. 19:828–837. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu M, Yin F, Yang L, Chen S, Chen R, Zhou
X, Jing W, Fan X, Jia R, Wang H, et al: Contribution of TIP30 to
chemoresistance in laryngeal carcinoma. Cell Death Dis.
5:e14682014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Capaccione KM and Pine SR: The Notch
signaling pathway as a mediator of tumor survival. Carcinogenesis.
34:1420–1430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ntziachristos P, Lim JS, Sage J and
Aifantis I: From fly wings to targeted cancer therapies: A
centennial for notch signaling. Cancer Cell. 25:318–334. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su BH, Qu J, Song M, Huang XY, Hu XM, Xie
J, Zhao Y, Ding LC, She L, Chen J, et al: NOTCH1 signaling
contributes to cell growth, anti-apoptosis and metastasis in
salivary adenoid cystic carcinoma. Oncotarget. 5:6885–6895. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu H, Zhao X, Huang S, Jian L, Qian G and
Ge S: Blocking Notch1 signaling by RNA interference can induce
growth inhibition in HeLa cells. Int J Gynecol Cancer. 17:511–516.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang L, Qin H, Chen B, Xin X, Li J and Han
H: Overexpressed active Notch1 induces cell growth arrest of HeLa
cervical carcinoma cells. Int J Gynecol Cancer. 17:1283–1292. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng Q, Qin H, Zhang H, Li J, Hou L, Wang
H, Zhang X, Zhang S, Feng L, Liang Y, et al: Notch signaling
inhibits growth of the human lung adenocarcinoma cell line A549.
Oncol Rep. 17:847–852. 2007.PubMed/NCBI
|
|
9
|
Ji X, Wang Z, Geamanu A, Sarkar FH and
Gupta SV: Inhibition of cell growth and induction of apoptosis in
non-small cell lung cancer cells by delta-tocotrienol is associated
with notch-1 down-regulation. J Cell Biochem. 112:2773–2783. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ito T, Udaka N, Okudela K, Yazawa T and
Kitamura H: Mechanisms of neuroendocrine differentiation in
pulmonary neuroendocrine cells and small cell carcinoma. Endocr
Pathol. 14:133–139. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kunnimalaiyaan M and Chen H: Tumor
suppressor role of Notch-1 signaling in neuroendocrine tumors.
Oncologist. 12:535–542. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeng Q, Li S, Chepeha DB, Giordano TJ, Li
J, Zhang H, Polverini PJ, Nor J, Kitajewski J and Wang CY:
Crosstalk between tumor and endothelial cells promotes tumor
angiogenesis by MAPK activation of Notch signaling. Cancer Cell.
8:13–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leethanakul C, Patel V, Gillespie J,
Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M and
Gutkind JS: Distinct pattern of expression of differentiation and
growth-related genes in squamous cell carcinomas of the head and
neck revealed by the use of laser capture microdissection and cDNA
arrays. Oncogene. 19:3220–3224. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hijioka H, Setoguchi T, Miyawaki A, Gao H,
Ishida T, Komiya S and Nakamura N: Upregulation of Notch pathway
molecules in oral squamous cell carcinoma. Int J Oncol. 36:817–822.
2010.PubMed/NCBI
|
|
15
|
Agrawal N, Frederick MJ, Pickering CR,
Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et
al: Exome sequencing of head and neck squamous cell carcinoma
reveals inactivating mutations in NOTCH1. Science. 333:1154–1157.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schacht V and Kern JS: Basics of
immunohistochemistry. J Invest Dermatol. 135:e302015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yap L, Lee D, Khairuddin A, Pairan M,
Puspita B, Siar C and Paterson I: The opposing roles of NOTCH
signalling in head and neck cancer: A mini review. Oral Dis. Jan
7–2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun W, Gaykalova DA, Ochs MF, Mambo E,
Arnaoutakis D, Liu Y, Loyo M, Agrawal N, Howard J, Li R, et al:
Activation of the NOTCH pathway in head and neck cancer. Cancer
Res. 74:1091–1104. 2014. View Article : Google Scholar :
|
|
19
|
Dang TP, Gazdar AF, Virmani AK, Sepetavec
T, Hande KR, Minna JD, Roberts JR and Carbone DP: Chromosome 19
trans-location, overexpression of Notch3, and human lung cancer. J
Natl Cancer Inst. 92:1355–1357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bedogni B, Warneke JA, Nickoloff BJ,
Giaccia AJ and Powell MB: Notch1 is an effector of Akt and hypoxia
in melanoma development. J Clin Invest. 118:3660–3670. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun JZ, Chen C, Jiang G, Tian WQ, Li Y and
Sun SR: Quantum dot-based immunofluorescent imaging of Ki67 and
identification of prognostic value in HER2-positive (non-luminal)
breast cancer. Int J Nanomed. 9:1339–1346. 2014. View Article : Google Scholar
|
|
22
|
Abdel Aziz MT, Khaled HM, El Hindawi A,
Roshdy NK, Rashed LA, Sabry D, Hassouna AA, Taha F and Ali WI:
Effect of mesenchymal stem cells and a novel curcumin derivative on
Notch1 signaling in hepatoma cell line. Biomed Res Int.
2013:1296292013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moriyama M, Osawa M, Mak SS, Ohtsuka T,
Yamamoto N, Han H, Delmas V, Kageyama R, Beermann F, Larue L, et
al: Notch signaling via Hes1 transcription factor maintains
survival of melanoblasts and melanocyte stem cells. J Cell Biol.
173:333–339. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Takeshita K, Liu PY, Satoh M, Oyama
N, Mukai Y, Chin MT, Krebs L, Kotlikoff MI, Radtke F, et al: Smooth
muscle Notch1 mediates neointimal formation after vascular injury.
Circulation. 119:2686–2692. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View
Article : Google Scholar
|
|
26
|
Cory S and Adams JM: Killing cancer cells
by flipping the Bcl-2/Bax switch. Cancer Cell. 8:5–6. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pelengaris S and Khan M: The many faces of
c-MYC. Arch Biochem Biophys. 416:129–136. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sriuranpong V, Borges MW, Ravi RK, Arnold
DR, Nelkin BD, Baylin SB and Ball DW: Notch signaling induces cell
cycle arrest in small cell lung cancer cells. Cancer Res.
61:3200–3205. 2001.PubMed/NCBI
|
|
29
|
Li X, He X, Tian W and Wang J: Short
hairpin RNA targeting Notch2 inhibits U87 human glioma cell
proliferation by inducing cell cycle arrest and apoptosis in vitro
and in vivo. Mol Med Rep. 10:2843–2850. 2014.PubMed/NCBI
|
|
30
|
Luo DH, Zhou Q, Hu SK, Xia YQ, Xu CC, Lin
TS, Pan YT, Wu JS and Jin R: Differential expression of Notch1
intracellular domain and p21 proteins, and their clinical
significance in gastric cancer. Oncol Lett. 7:471–478.
2014.PubMed/NCBI
|
|
31
|
Zhou L, Zhang N, Song W, You N, Li Q, Sun
W, Zhang Y, Wang D and Dou K: The significance of Notch1 compared
with Notch3 in high metastasis and poor overall survival in
hepatocel-lular carcinoma. PLoS One. 8:e573822013. View Article : Google Scholar
|
